Biotech Values

[ghmm]

FGEN:

Is there a reason to use the Denominator's of 14 and 11 (vs excluding those still on treatment 5 and 3). Wouldn't those still on treatment still be potentially able to become resectable?

I agree in the numbers are too small to form any real conclusions. When things were 100% or 83% (5/5 or 5/6) vs 1 (in 7 I believe) as presented earlier there was hope that small numbers could be conclusive but how the numbers are now we need to see more patients and the data mature. I don't consider the results bad though just not yet conclusive.